Results from The HUNT Study on The Role of Plasma miR-145-5p Levels in Cancer-Associated VTE – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Christopher Antoun et al, adding:
”Plasma miR-145-5p levels and risk of cancer-associated thrombosis — results from the HUNT study
Higher plasma miR-145-5p levels are significantly associated with reduced risk of both cancer-associated and non-cancer-associated venous thromboembolism, positioning this microRNA as a promising biomarker for thrombosis risk stratification in cancer patients.”
Title: Plasma miR-145-5p levels and risk of cancer-associated thrombosis—results from the HUNT study
Authors: Christopher Antoun, Julia Oto, Raquel Herranz, Pilar Medina, Vania M. Morelli, Kristian Hveem, Sigrid K. Brækkan, John-Bjarne Hansen
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges
-
Apr 15, 2026, 14:29Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins
-
Apr 15, 2026, 14:25Prince Alfred Singh։ Understanding Antithrombin III Deficiency as a High-Risk Thrombophilia